Lisa Johnson, MD
Urogynecology and Reconstructive Pelvic Surgery · Oak Lawn, ILNPI 1629069919
Payments from drug & device makers
What this record shows
This record is dominated by education: $18,102 of the $24,060 with a category attached, or 75.2%. Coloplast accounts for 92.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2021 at $10,303 and has fallen 90.6% since, to $968 in 2025.
Across 71 payments — averaging $338.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$22K
- Intuitive Surgical$852
- AbbVie$502
- Contura, Inc.$95
- Axonics, Inc.$64
- Hologic Sales And Service, LLC$63
- plus $184 from 5 others
What the payments were for
- Travel & lodging$2,93512%
- Food & beverage$3,02313%
- Education$18,10275%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 31 | $22,300 |
| Intuitive Surgical | 5 | $852 |
| AbbVie(2 entities) | 20 | $502 |
| Contura, Inc. | 1 | $95 |
| Axonics, Inc. | 3 | $64 |
| Hologic Sales And Service, LLC | 3 | $63 |
| Medtronic | 2 | $54 |
| Astellas Pharma US Inc | 2 | $45 |
| Coopersurgical, Inc. | 2 | $40 |
| Vertex | 1 | $27 |
| Antares Pharma, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALTIS$22,038
- Da Vinci Surgical System$723
How this compares
$24,060 in reported general payments places this provider in the 85th percentile of 62 urogynecology and reconstructive pelvic surgery providers in Illinois.
See all urogynecology and reconstructive pelvic surgery providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 20 | $1,795 |
| Oxybutynin Chloride ErOxybutynin Chloride | 21 | $185 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 13 | $94 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 22 | $32 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Oak Lawn
- Denise PoulosOak Lawn$8K
- Abraham ShashouaChicago$339K
- Peter SandSkokie$185K
- Akira GillinghamChicago$58K
- Roger GoldbergSkokie$54K
- Kimberly KentonChicago$43K
- Traci BeckChicago$32K
- Raja ChatterjiSouth Elgin$30K
- Margaret MuellerChicago$26K
- Henry ChillEvanston$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.